{"disease":{"id":"squamous-cell-carcinoma-of-the-anal-canal","name":"squamous cell carcinoma of the anal canal"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04472429","title":"Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":308,"lead_sponsor_name":"Incyte Corporation","has_results":true},{"nct_id":"NCT07455942","title":"Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Centre Hospitalier Intercommunal Creteil","has_results":false},{"nct_id":"NCT04580485","title":"INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT03946358","title":"Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Centre Hospitalier Universitaire de Besancon","has_results":false},{"nct_id":"NCT05201105","title":"Tumor Recurrence After Abdominal-perineal Amputation in Squamous Cell Carcinoma of the Anus","phase":"","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Fondation Hôpital Saint-Joseph","has_results":false},{"nct_id":"NCT03357757","title":"Avelumab With Valproic Acid in Virus-associated Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"AHS Cancer Control Alberta","has_results":false},{"nct_id":"NCT04221893","title":"Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers","phase":"NA","overall_status":"RECRUITING","enrollment_count":28,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06910137","title":"An Early Access Program Guideline to Provide Access to Retifanlimab (INCMGA00012) Together With Carboplatin and Paclitaxel for Squamous Carcinoma of the Anal Canal (SCAC)","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Incyte Corporation","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}